XLVX
Corgi U.S. Healthcare 2x Daily ETF
$38.43
ETFs Similar to XLVX
Comparison Results
| Name | Price | Price Change | Price Target | Smart Score | Expense Ratio | Asset Under Management | Follow |
|---|---|---|---|---|---|---|---|
| XLVHealth Care Select Sector SPDR Fund | $184.80 | $196.87(6.53% Upside) | 0.08% | 49.72B | |||
| VHTVanguard Health Care ETF | $341.23 | $382.69(12.15% Upside) | 0.09% | 20.97B | |||
| IBBiShares Biotechnology ETF | $213.63 | $266.26(24.64% Upside) | 0.44% | 10.89B | |||
| XBISPDR S&P BIOTECH ETF | $152.21 | $242.60(59.39% Upside) | 0.35% | 10.06B | |||
| IYHiShares U.S. Healthcare ETF | $77.48 | $83.69(8.02% Upside) | 0.37% | 4.74B | |||
| IXJiShares Global Healthcare ETF | $112.96 | $120.51(6.68% Upside) | 0.38% | 4.64B | |||
| IHIiShares U.S. Medical Devices ETF | $57.59 | $62.72(8.90% Upside) | 0.37% | 4.13B | |||
| FHLCFidelity MSCI Health Care Index ETF | $88.22 | $97.51(10.53% Upside) | 0.08% | 4.02B |
International Listings
OTC and non-US listings of funds similar to XLVX.
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| XLV | Health Care Select Sector SPDR Fund | 184.80 | 39.94 | 27.57% | |
| VHT | Vanguard Health Care ETF | 341.23 | 70.80 | 26.18% | |
| IBB | iShares Biotechnology ETF | 213.63 | 54.41 | 34.17% | |
| XBI | SPDR S&P BIOTECH ETF | 152.21 | 42.59 | 38.85% | |
| IYH | iShares U.S. Healthcare ETF | 77.48 | 16.26 | 26.56% | |
| IXJ | iShares Global Healthcare ETF | 112.96 | 21.42 | 23.40% | |
| IHI | iShares U.S. Medical Devices ETF | 57.59 | -3.88 | -6.31% | |
| FHLC | Fidelity MSCI Health Care Index ETF | 88.22 | 18.36 | 26.29% |
ETFs Similar to XLVX FAQ
What is the cheapest alternative to XLVX?
Among the ETFs similar to XLVX, XLV (Health Care Select Sector SPDR Fund) has the lowest expense ratio, at 0.08% a year, compared with 0.45% for XLVX.
XLVX vs. XLV: what is the difference?
XLV (Health Care Select Sector SPDR Fund) is the first ETF in XLVX's similar-ETF list. It has $49.72B in assets under management and a 0.08% expense ratio, against $1.73M and 0.45% for XLVX. Compare their performance, price targets and Smart Scores in the table above.

